Pharmacokinetics and disposition of flupirtine in the horse.
Authors: Giorgi M, De Vito V, Poapolathep A, Rychshanova R, Sgorbini M, Owen H
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary: Flupirtine Pharmacokinetics in Horses Flupirtine is a non-opioid analgesic licensed for human pain management that lacks the anti-inflammatory and antipyretic properties of conventional equine analgesics, making it a potentially valuable alternative for conditions where these effects are undesirable. Giorgi and colleagues administered flupirtine to six mares via intravenous injection (1 mg/kg) and oral nasogastric administration (5 mg/kg) in a crossover design, collecting plasma samples over 48 hours and measuring drug concentrations using high-performance liquid chromatography. The drug remained detectable for up to 36 hours after both routes; however, oral absorption proved substantially slower than intravenous clearance, with a longer elimination half-life of 10.27 hours following oral dosing compared to 3.02 hours intravenously, whilst oral bioavailability averaged 71.4%. Pharmacokinetic modelling suggested an oral dose of 2.6 mg/kg would achieve plasma concentrations comparable to clinically effective human levels, with mild and transient adverse effects observed in only two intravenously treated animals. These preliminary findings establish basic pharmacological parameters for flupirtine in horses and provide a foundation for clinical efficacy studies, though practitioners should await further research before considering this agent for routine analgesic protocols in equine practice.
Read the full abstract on PubMed
Practical Takeaways
- •Flupirtine appears to be a well-tolerated non-opioid analgesic option for equine pain management with minimal side effects compared to traditional analgesics
- •An oral dose of approximately 2.6 mg/kg may be more practical than IV administration for achieving therapeutic pain relief in horses, based on pharmacokinetic modeling
- •Further clinical trials are needed to establish safety and efficacy protocols for flupirtine use in equine practice before widespread adoption
Key Findings
- •Flupirtine was detectable in equine plasma for up to 36 hours after both IV and PO administration
- •Oral bioavailability of flupirtine in horses was 71.4 ± 33.1% with longer elimination half-life after PO (10.27 h) than IV (3.02 h) administration
- •An oral dose of 2.6 mg/kg was calculated to achieve plasma concentrations in horses similar to clinically effective human doses (target 187 ng/mL)
- •Only mild and transient adverse effects occurred in 2/6 horses after IV administration with no adverse effects observed after oral administration